IN JANUARY 2023, US-based short-seller Hindenburg Research came out with a report accusing the Adani Group of indulging in billions of dollars' worth of undisclosed related party transactions, investment and stock manipulation. Now, the controversy has reached the doorstep of India's capital markets regulator, the Securities and Exchange Board of India (Sebi).
Hindenburg has launched a direct attack on Sebi Chairperson Madhabi Puri Buch and the regulatory body, alleging that Sebi has shown a lack of interest in probing the Adani Group's alleged undisclosed network of shell entities. Sebi, Buch, and the Adani Group have all refuted the latest allegations.
In its latest report, Hindenburg has connected the alleged links of the Sebi chief's family with the Adani Group as reason for the delay in the investigation. "We suspect Sebi's unwillingness to take meaningful action against suspect offshore shareholders in the Adani Group may stem from [the] Chairperson's complicity in using the exact same funds used by Vinod Adani, brother of Gautam Adani," the US-based short-seller states. "To date, Sebi has taken no action against other suspected Adani shareholders operated by IIFL: EM Resurgent Fund and Emerging India Focus Funds," it adds.
It alleges Buch and her husband, Dhaval Buch, had stakes in the same offshore funds-Global Dynamic Opportunities Fund (GDOF) and IPE Plus Fund 1-found in the same complex nested structure used by Vinod Adani.
Esta historia es de la edición 1st September 2024 de Business Today India.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.
Ya eres suscriptor ? Conectar
Esta historia es de la edición 1st September 2024 de Business Today India.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.
Ya eres suscriptor? Conectar
BUILDING TOMORROW'S CARE TODAY
The Indian pharma industry is at a juncture where digital transformation is sweeping the healthcare landscape
BIG SHOTS
GIVEN THAT MORE THAN 40% OF INDIAN ADULTS ARE STRUGGLING WITH OBESITY AND DIABETES, AFFORDABLE WEIGHT-LOSS DRUGS ARE EXPECTED TO SIGNIFICANTLY DISRUPT THE PHARMACEUTICAL LANDSCAPE IN THE COUNTRY THIS YEAR. AND, THE WEIGHT MANAGEMENT MARKET COULD REACH ₹3.99 LAKH CRORE BY 2032, GROWING AT A CAGR OF MORE THAN 9%
THE END OF AMERICAN FINANCIAL EXCEPTIONALISM
As the dollar cycle reverses and Asia's rise continues, Indian growth will accelerate
HOW TO ADAPT TO EXTREME HEAT
India is vulnerable to extreme heat and yet unprepared. But various initiatives provide a glimpse of what is possible when collaboration and ingenuity come together
THE WORLD IN 2030
The policy implications are that India would have to maintain a strong link to a re-industrialising US but find a way to use Chinese capital and inputs
A PEEK INTO THE FUTURE
INDIA IN 2025 AND BEYOND: TRENDS TO WATCH OUT FOR
"STEERING SBI INTO THE FUTURE"
C.S. Setty, Chairman of the State Bank of India, talks about his plans for the bank, the strategy for the future, and technology, among other things
"Outlook for India is very positive"
Paul Uren, Head of Investment Banking (Asia-Pacific), J. P. Morgan, on M&A activity, the environment of investment banking market in India, and more
The 2025 Slate
The Indian film industry is hoping that 2025 will mark the return of big-budget blockbusters
TECH, SET, GO!
With up to 30 tech start-ups looking to go public, the year promises to be a turning point for India's thriving start-up ecosystem